Trademark Acknowledgment: Zevay is the trade name used by Zevay, LLC in the materials reviewed for this article
Asian Pac J Allergy Immunol (2016) 34:3005
Grading of Recommendations Assessment, Development and Evaluation (GRADE) showed moderate certainty for MACE, all-cause death and hospitalization for HF
The right site will depend on several individual factors, including body composition, personal comfort, ease of access, and any pre-existing skin conditions at potential injection areas
Substantial and sustained weight loss, even in individuals without diabetes
Efficacy and expected weight loss Clinical trial results suggest both drugs help people lose significant weight compared to lifestyle alone, with many patients seeing double-digit percent weight loss over months